Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ) - Enterprise Valueverified

XVIPY

Price:

$7.1288

Market Cap:

$8.10B

Xvivo Perfusion AB (publ), a medical technology enterprise based in Gothenburg, Sweden, specializes in developing cutting-edge solutions for the preservation and perfusion of organs, tissues, and cells, crucial for transplantation. The company's reach spans diverse global markets, including Sweden, the United States, broader North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its extensive product lineup features the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system engineered for secure normothermic ex vivo lung perfusion (EVLP). This is supported by the XPS Disposable Lung Kit, which supplies all necessary sterile consumables. Xvivo Pe...[Read more]

Industry

Medical - Devices

IPO Date

2022-09-23

Stock Exchange

OTC

Ticker

XVIPY

The Enterprise Value as of July 2026 (TTM) for Xvivo Perfusion AB (publ) (XVIPY) is 7.91B

According to Xvivo Perfusion AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 7.91B. This represents a change of 21.04% compared to the average of 6.54B of the last 4 quarters.

Xvivo Perfusion AB (publ) (XVIPY) Historical Enterprise Value (quarterly & annually)

How has XVIPY Enterprise Value performed in the past?

The mean historical Enterprise Value of Xvivo Perfusion AB (publ) over the last ten years is 6.29B. The current 7.91B Enterprise Value has changed 12.49% with respect to the historical average. Over the past ten years (40 quarters), XVIPY's Enterprise Value was at its highest in in the September 2024 quarter at 15.67B. The Enterprise Value was at its lowest in in the September 2016 quarter at 1.75B.

Quarterly (TTM)
Annual

Average

6.29B

Median

5.44B

Minimum

1.96B

Maximum

15.02B

Xvivo Perfusion AB (publ) (XVIPY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Xvivo Perfusion AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 87.98%

Maximum Annual Enterprise Value = 15.02B

Minimum Annual Increase = -61.99%

Minimum Annual Enterprise Value = 1.96B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20255.71B-61.99%
202415.02B60.67%
20239.35B80.95%
20225.17B-32.38%
20217.64B-6.66%
20208.19B87.98%
20194.35B32.53%
20183.29B49.94%
20172.19B11.65%
20161.96B61.20%

Xvivo Perfusion AB (publ) (XVIPY) Average Enterprise Value

How has XVIPY Enterprise Value performed in the past?

The current Enterprise Value of Xvivo Perfusion AB (publ) (XVIPY) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

10.03B

5-year avg

8.58B

10-year avg

6.29B

Xvivo Perfusion AB (publ) (XVIPY) Enterprise Value vs. Peers

How is XVIPY’s Enterprise Value compared to its peers?

Xvivo Perfusion AB (publ)’s Enterprise Value is greater than EBR Systems, Inc. (139.91M), greater than TerrAscend Corp. (362.24M), less than Adcock Ingram Holdings Limited (11.12B), greater than Ceryvyn Therapeutics Limited (-9753049.94), greater than PeakBirch Commerce Inc. (545.56M), greater than SS Innovations International, Inc. (768.35M), greater than Kindstar Globalgene Technology, Inc. (866.19M), greater than Columbia Care Inc. (808.75M), greater than Supermax Corporation Berhad (335.67M), less than PT Tempo Scan Pacific Tbk (9.05T),

Build a custom stock screener for Xvivo Perfusion AB (publ) (XVIPY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xvivo Perfusion AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xvivo Perfusion AB (publ) (XVIPY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xvivo Perfusion AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Xvivo Perfusion AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for Xvivo Perfusion AB (publ) (XVIPY)?

What is the 3-year average Enterprise Value for Xvivo Perfusion AB (publ) (XVIPY)?

What is the 5-year average Enterprise Value for Xvivo Perfusion AB (publ) (XVIPY)?

How does the current Enterprise Value for Xvivo Perfusion AB (publ) (XVIPY) compare to its historical average?